Johns Hopkins ABX Guide
Lincomycin
INDICATIONS
FDA
FDA
- Treatment of serious infections caused by susceptible strains of streptococci, pneumococci, and staphylococci in PCN-allergic patients.
- Only IV formulation is available in the U.S.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 14, 2024
Citation
Auwaerter, Paul G, and . "Lincomycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540314/all/Lincomycin.
Auwaerter PG, . Lincomycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540314/all/Lincomycin. Accessed January 20, 2025.
Auwaerter, P. G., & , . (2024). Lincomycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540314/all/Lincomycin
Auwaerter PG, . Lincomycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. [cited 2025 January 20]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540314/all/Lincomycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lincomycin
ID - 540314
A1 - Auwaerter,Paul,M.D.
AU - ,,
Y1 - 2024/12/14/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540314/all/Lincomycin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
